Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Stomach Neoplasms 38Pancreatic Neoplasms 11Esophageal Neoplasms 8Biliary Tract Neoplasms 8Colorectal Neoplasms 7Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Overall Survival 1Nasopharyngeal Carcinoma 1Hand-Foot Syndrome 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Advanced Pancreatic Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × S 1 (combination) × Clear all
NCT00400023 2024-09-03

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Taiho Oncology, Inc.

Phase 1 Completed
12 enrolled
Tumor-Agnostic

Neoplasms

NCT00479076 2011-01-26

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Sanofi

Phase 1 Completed
22 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡